Vcanbio Cell & Gene Engineering Corp., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. is a life technology innovation enterprise with the core vision of developing "precision medicine" (stock code: 600645). The company focuses on three major sub areas: "precision prevention," "precision diagnosis," and "precision treatment." Its main business covers the entire industry chain, including cell storage, gene testing, new drug research and development, and the research, production, and sales of in vitro diagnostic reagents, genes, proteins, and antibodies. The company has advanced cell technology and a national cell resource storage network, with a cell storage capacity of over 300000 copies. It is one of the important research and development and transformation bases for cell technology products in the country. |
| Headquarter | Tianjin |
| Establish Date | 6/14/1995 |
| Listed Code | 600645.SH |
| Listed Date | 5/4/1993 |
| Chairman | Gong Hongjia. |
| CEO | Wang Yong. |
| Website | www.vcanbio.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
